This article has Open Peer Review reports available.
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments
- Peter Connick†1, 2, 4Email author,
- Madhan Kolappan†3,
- Rickie Patani1, 2,
- Michael A Scott3,
- Charles Crawley3,
- Xiao-Ling He2,
- Karen Richardson3,
- Kelly Barber3,
- Daniel J Webber2,
- Claudia AM Wheeler-Kingshott3,
- Daniel J Tozer3,
- Rebecca S Samson3,
- David L Thomas5,
- Ming-Qing Du6,
- Shi L Luan6,
- Andrew W Michell1,
- Daniel R Altmann7,
- Alan J Thompson8,
- David H Miller3,
- Alastair Compston1 and
- Siddharthan Chandran2, 9
© Connick et al; licensee BioMed Central Ltd. 2011
Received: 5 November 2010
Accepted: 2 March 2011
Published: 2 March 2011
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|5 Nov 2010||Submitted||Original manuscript|
|7 Feb 2011||Reviewed||Reviewer Report - Letizia Mazzini|
|7 Feb 2011||Reviewed||Reviewer Report - Franca Fagioli|
|18 Feb 2011||Author responded||Author comments - Peter Connick|
|Resubmission - Version 2|
|18 Feb 2011||Submitted||Manuscript version 2|
|2 Mar 2011||Editorially accepted|
|2 Mar 2011||Article published||10.1186/1745-6215-12-62|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.